Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)*
Finance & Acquisitions: Recursion
Cyclica

Organization & Developments: Cyclica

Parents

*Cyclica brings a focus on oncology and central nervous system diseases with an AI-enabled platform that predicts the polypharmacology of small molecules — including how they interact with a wide swath of proteins — in order to advance small molecule drug discovery.
Cyclica drives drug discovery by empowering scientists in pharma with an integrated cloud-based and AI-augmented platform that enhances how they design, screen, and personalize medicines, all with novel, IP-protected tech.
Ligand Express®, Cyclica’s flagship technology, is a drug-centric, structure-based platform that is supported by AI and machine learning techniques, and provides insights into a drug’s polypharmacology (i.e off-target interactions) for the pharmaceutical, nutraceutical, and cosmeceutical industries.